LungLife AI, Inc.
LLAI.L · LSE
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Revenue | £0 | £0 | £0 | £0 |
| % Growth | 91.7% | -87.7% | -4.7% | – |
| Cost of Goods Sold | £0 | £0 | £0 | £0 |
| Gross Profit | £0 | £0 | £0 | £0 |
| % Margin | 100% | 100% | 50.8% | 8.3% |
| R&D Expenses | £1 | £2 | £1 | £1 |
| G&A Expenses | £1 | £7 | £2 | £4 |
| SG&A Expenses | £1 | £7 | £2 | £4 |
| Sales & Mktg Exp. | £0 | £0 | £0 | £0 |
| Other Operating Expenses | £3 | -£1 | £2 | £0 |
| Operating Expenses | £6 | £8 | £5 | £4 |
| Operating Income | -£6 | -£8 | -£5 | -£4 |
| % Margin | -12,243.5% | -31,825% | -2,732.6% | -1,979.6% |
| Other Income/Exp. Net | £0 | £0 | -£0 | -£1 |
| Pre-Tax Income | -£5 | -£8 | -£7 | -£5 |
| Tax Expense | £0 | £0 | £0 | £1 |
| Net Income | -£5 | -£8 | -£7 | -£6 |
| % Margin | -11,767.4% | -31,691.7% | -3,806.5% | -2,737.2% |
| EPS | -0.21 | -0.3 | -0.47 | -0.22 |
| % Growth | 30% | 36.2% | -113.6% | – |
| EPS Diluted | -0.21 | -0.3 | -0.47 | -0.22 |
| Weighted Avg Shares Out | 25 | 25 | 16 | 25 |
| Weighted Avg Shares Out Dil | 25 | 25 | 16 | 25 |
| Supplemental Information | – | – | – | – |
| Interest Income | £0 | £0 | £0 | £0 |
| Interest Expense | £0 | £0 | £0 | £1 |
| Depreciation & Amortization | £0 | £0 | £0 | £0 |
| EBITDA | -£5 | -£7 | -£7 | -£4 |
| % Margin | -11,110.9% | -30,270.8% | -3,419.8% | -1,841.9% |